ClinicalTrials.gg
RecruitingNCT07733960CSP DisplayUpdated Jul 29, 2026

Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer

An observational study in Bradycardia, sponsored by Medtronic Cardiac Rhythm and Heart Failure. Recruiting at 2 sites in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Medtronic Cardiac Rhythm and Heart Failure (part of Medtronic) · Observational

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to collect and compare the heart's electrical activity data measured by the novel Conduction System Pacing (CSP) Display Research System with data measured via 12 lead electrocardiogram (ECG) from a commercially available, standard of care electro-physiology (EP) monitoring and recording device during the pacemaker implantation. Participants receiving a routine de-novo implantation of a pacemaker for left bundle branch area pacing (LBBAP) will undergo the CSP Display System protocol during the implant procedure.

Read the detailed description

This feasibility study evaluates the use of the CSP Display Research System during single- or dual-chamber pacemaker implantation for left bundle branch area pacing (LBBAP). The system provides visualization of electrocardiogram data and automatic measurement of left ventricular activation time. Measurements using the CSP Display Research System will be compared with measurements obtained from a standard electrophysiology (EP) recording system used during the implant procedure as part of standard clinical practice. This study also includes exploratory collection of electrocardiogram, intracardiac electrogram, pacemaker marker channel, and left ventricular activation time data during the implant procedure to support future research and algorithm development. These data will be collected for exploratory purposes and do not have a pre-specified evaluation in this study.

02

Conditions studied

  • Bradycardia

Browse trials for

Keywords

  • Left bundle branch area pacing (LBBAP)
03

In context

Bradycardia

317 studies on the registry are indexed under Bradycardia; 71 are open to participants now.

This study's planned enrollment of 100 is below the median of 257 across 127 observational studies indexed under Bradycardia.

Browse Bradycardia studies →

Lead sponsor

Medtronic Cardiac Rhythm and Heart Failure is the lead sponsor of 240 studies on the registry; 4 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 18 (95%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The target population for the CSP Display study will include subjects who are indicated to receive a de-novo pacemaker implant (single or dual chamber) with left bundle branch area pacing (LBBAP) based on market approved indications.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject is at least 18 years of age
  • Subject is willing and able to provide written
  • Subject is willing and able to comply with the protocol
  • Subject meets eligibility for de-novo implant of a pacemaker (single or dual chamber) with left bundle branch area pacing (LBBAP) therapy

Exclusion criteria

Exclusion Criteria:

  • Subject is not available to comply with visit schedule
  • Pregnant or breastfeeding woman (pregnancy test required for woman of and who are not on a reliable form of birth regulation method or abstinence)
  • Subject is currently enrolled or planning to enroll in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study.
  • Subject meets any exclusion criteria required by local law
  • Vulnerable adults (i.e. subjects incapable of giving consent)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients receiving a clinically indicated single- or dual-chamber pacemaker implantation

    Patients with left bundle branch area pacing will have measurements collected using the CSP Display Research System for visualisation of surface electrocardiogram data and automatic measurement of left ventricular activation time for comparison with a standard electrophysiology recording system.

    Device: CSP Display research system

Interventions

  • DeviceCSP Display research system

    Research system used during pacemaker implantation to visualize surface electrocardiogram data and automatically measure left ventricular activation time

06

What researchers measure

Primary outcomes

  1. Left Ventricular Activation Time (LVAT)

    LVAT measured using the CSP Display Research System and a commercial electrophysiology recording system

    Time frame: During pacemaker implant procedure

Secondary outcomes

  1. Surface ECG V1 morphology

    V1 morphology observed using the CSP Display Research System and a commercial electrophysiology recording system.

    Time frame: During pacemaker implant procedure

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07733960
Responsible party
Sponsor
First posted
Jul 29, 2026
Start date
May 21, 2026
Primary completion
Jul 30, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Jul 29, 2026

Study contacts

Sr Director - Clinical Research and Medical Science, Medtronic
Contact
vinay.rajan@medtronic.com
+91-2233074700

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion